AstraZeneca, GSK, Teva All On FTC’s Notice Due To “Improperly Listed” Patents
The U.S. Federal Trade Commission (FTC) issued letters to various medical device companies and drugmakers, including AbbVie, AstraZeneca, and subsidiaries
Read moreThe U.S. Federal Trade Commission (FTC) issued letters to various medical device companies and drugmakers, including AbbVie, AstraZeneca, and subsidiaries
Read moreCanada is poised to move forward with a significant change in its medical assistance in dying (MAID) policy. The nation
Read moreOn the first day of trading following the Pfizer’s (NYSE: PFE) announcement of weaker-than-expected sales for its COVID-19 vaccine and
Read moreIn what is gearing up to be an unprecedented event, over 75,000 dedicated healthcare workers employed by Kaiser Permanente, the
Read moreDiagnaMed Holdings (CSE: DMED) is moving forward with the commercialization of CERVAI, its brain health AI platform.
Read moreTwo and a half years after going public following a $175 million financing, Neighbourly Pharmacy (TSX: NBLY) is looking to
Read moreFour years after going public in an $8.9 billion IPO transaction, SmileDirectClub (NASDAQ: SDC) filed for bankruptcy. The filing came
Read moreAfter seeing its lenders foreclosure on certain of its US operations, Skylight Health (TSXV: SLHG) is reporting that it no
Read moreEarlier this week, YouTube unveiled a refined policy aimed at curbing medical misinformation on its platform. The company plans to
Read moreThe end of the line has finally come for Skylight Health (TSXV: SLHG), who announced late yesterday that it has
Read more